Replies to post #37 on China Biologic Products, Inc. (CBPO)

[GorillaGorilla]

All this information is freely available in the 10-Q's and K's but thank you, again, for bringing this to our notice. There are only a limited number of licenese to collect blood products - CBPO had little choice about who they deal with. As far as I can understand all these court cases came about because of the people they bought the collection stations from; who clearly are a bunch of criminals. That said CBPO has been entrusted to clear up the mess that is blood products - will they do this? Well, I haven't seen some malpractice generated by the operations of the company or by the directors been directly involved in wrong doings. Have you?

rich

[abh3vt]

I was going to respond more fully to you until I saw this (which indicates to me that you have made up your mind already):

I move on and am done with this.

I'm not sure there are any explanations or reasoned arguments that will change your outlook. All I can say is that the company has an equally strong position that is opposite to Mr. Du's regarding the basis of the lawsuit. I wish that it could have been settled long ago, and the longer it hangs around will give posters like you stuff to speculate about.

I think you are way off base in your speculation about the worst case scenario for US shareholders. I would also refer you to recent SEC filings that show several large and sophisticated investors have made substantial investments in this company this year with full knowledge of this (and other) lawsuits that the company has been facing.

Since you seem to enjoy doing this type of DD, why don't you report back to us on the identity of the institutional investors who have taken a position in CBPO? Perhaps give a more nuanced view of the investment opportunity here rather than slam the company on two public bulletin boards?